{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:12:00Z","timestamp":1792141920656,"version":"4.4.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Polidocanol is an FDA-approved treatment of incompetent great saphenous veins, accessory saphenous veins, and visible varicosities of the great saphenous vein system, but numerous other off-label dermatological applications have been reported.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To describe the various off-label dermatological clinical uses of polidocanol, as well as efficacy and adverse effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>The review of studies searchable on PubMed from 2004 to 2021 describing clinical uses of polidocanol to determine efficacy and adverse effects associated with various dermatologic applications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Polidocanol has shown efficacy in the treatment of mucocele of minor salivary gland, hemangioma, upper extremity veins, reticular veins of the chest, facial veins, pyogenic granuloma, lymphangioma circumscriptum, digital mucous cyst, mixed skin ulcers, cutaneous focal mucinosis, seromas, glomuvenous malformations, acne cysts, lymphocele, and dissecting cellulitis. Commonly reported side effects include pain, erythema, swelling, ecchymosis, and ulceration. Most sources were case reports and small prospective studies, as such the strength of data supporting many uses is limited by small sample sizes and lack of controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Although polidocanol is currently only FDA approved for incompetent great saphenous veins, accessory saphenous veins, and visible varicosities of the great saphenous vein system, the use of polidocanol has been selected for a variety of off-label clinical applications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000003520","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T14:00:36Z","timestamp":1655992836000},"page":"961-966","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Polidocanol: A Review of Off-Label Dermatologic Uses"],"prefix":"10.1097","volume":"48","author":[{"given":"Quoc-Bao D.","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Texas McGovern Medical School at Houston, Houston, Texas;"},{"name":"Department of Dermatology, MD Anderson Cancer Center, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Stender","sequence":"additional","affiliation":[{"name":"McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delfina","family":"Bur","sequence":"additional","affiliation":[{"name":"McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirunya","family":"Silapunt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas McGovern Medical School at Houston, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/0268355514534648","article-title":"Interaction of detergent sclerosants with cell membranes","volume":"30","author":"Parsi","year":"2015","journal-title":"Phlebology"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejvs.2008.03.001","article-title":"The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro","volume":"36","author":"Parsi","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1524-4725.2012.02422.x","article-title":"Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline","volume":"38","author":"Peterson","year":"2012","journal-title":"Dermatol Surg"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1517\/13543780903376163","article-title":"Polidocanol for endovenous microfoam sclerosant therapy","volume":"18","author":"Eckmann","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejvs.2010.10.004","article-title":"In vitro effects of detergent sclerosants on clot formation and fibrinolysis","volume":"41","author":"Parsi","year":"2011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"e20200178","DOI":"10.1590\/1677-5449.200178","article-title":"Bilateral foam polidocanol sclerotherapy of great saphenous veins and their tributaries in synchronous procedure","volume":"20","author":"Miranda","year":"2021","journal-title":"J Vasc Bras"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1001\/archderm.139.11.1494","article-title":"Foam sclerotherapy: a new era","volume":"139","author":"Hsu","year":"2003","journal-title":"Arch Dermatol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.semvascsurg.2004.12.007","article-title":"Saphenous ablation: sclerosant or sclerofoam?","volume":"18","author":"Coleridge Smith","year":"2005","journal-title":"Semin Vasc Surg"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0268355514554476","article-title":"Modified Tessari Tourbillon technique for making foam sclerotherapy with silicone-free syringes","volume":"30","author":"Whiteley","year":"2015","journal-title":"Phlebology"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00042728-200501000-00004","article-title":"Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique","volume":"31","author":"Rao","year":"2005","journal-title":"Dermatol Surg"},{"key":"R12-20250731","first-page":"58","article-title":"Preliminary experience with a new sclerosing foam in the treatment of varicose veins","volume":"27","author":"Tessari","year":"2001","journal-title":"Dermatol Surg"},{"key":"R14-20250731","first-page":"1124","article-title":"Improper potency and impurities in compounded polidocanol","volume":"18","author":"Mann","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"R15-20250731","first-page":"1454","article-title":"Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe?","volume":"30","author":"Goldman","year":"2004","journal-title":"Dermatol Surg"},{"key":"R16-20250731","first-page":"812","article-title":"Absence of concentration congruity in six compounded polidocanol samples obtained for leg sclerotherapy","volume":"37","author":"Weiss","year":"2011","journal-title":"Dermatol Surg"},{"key":"R17-20250731","first-page":"1037","article-title":"FDA-approved sodium tetradecyl sulfate (STS) versus compounded STS for venous sclerotherapy","volume":"33","author":"Almeida","year":"2007","journal-title":"Dermatol Surg"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archderm.1987.01660330107021","article-title":"Sclerosing agents in the treatment of telangiectasia. Comparison of the clinical and histologic effects of intravascular polidocanol, sodium tetradecyl sulfate, and hypertonic saline in the dorsal rabbit ear vein model","volume":"123","author":"Goldman","year":"1987","journal-title":"Arch Dermatol"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/0378-6323.77478","article-title":"Standard guidelines for care: sclerotherapy in dermatology","volume":"77","author":"Khunger","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00042728-200506000-00003","article-title":"Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins","volume":"31","author":"Rao","year":"2005","journal-title":"Dermatol Surg"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000445436","article-title":"Safety concerns for sclerotherapy of telangiectases, reticular and varicose veins","volume":"98","author":"Yiannakopoulou","year":"2016","journal-title":"Pharmacology"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejvs.2005.08.018","article-title":"Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial","volume":"31","author":"Al\u00f2s","year":"2006","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/DSS.0000000000001876","article-title":"Safety profile of sclerosing agents: an analysis from the World Health Organization Pharmacovigilance Database VigiBase","volume":"45","author":"Roselli","year":"2019","journal-title":"Dermatol Surg"},{"issue":"Suppl 1","key":"R24-20250731","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1258\/phleb.2012.012s09","article-title":"Complications of foam sclerotherapy","volume":"27","author":"Cavezzi","year":"2012","journal-title":"Phlebology"},{"key":"R25-20250731","first-page":"52","article-title":"Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol","volume":"28","author":"Goldman","year":"2002","journal-title":"Dermatol Surg"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/jop.12764","article-title":"The efficacy of polidocanol sclerotherapy in mucocele of the minor salivary gland","volume":"47","author":"Liu","year":"2018","journal-title":"J Oral Pathol Med"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"e12568","DOI":"10.1111\/dth.12568","article-title":"Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations: a meta-analysis","volume":"31","author":"Gao","year":"2018","journal-title":"Dermatol Ther"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1524-4725.2000.98012.x","article-title":"Sclerotherapy for treatment of hemangiomas","volume":"26","author":"Winter","year":"2000","journal-title":"Dermatol Surg"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1111\/j.1524-4725.2010.01760.x","article-title":"Combination of oral corticosteroids and polidocanol sclerotherapy in the management of infantile hemangiomas","volume":"36","author":"Grover","year":"2010","journal-title":"Dermatol Surg"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/0974-2077.101383","article-title":"Sclerotherapy for the treatment of infantile hemangiomas","volume":"5","author":"Grover","year":"2012","journal-title":"J Cutan Aesthet Surg"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1053\/j.jfas.2014.06.008","article-title":"Two different treatment options for intramuscular plantar hemangioma: surgery versus percutaneous sclerotherapy","volume":"53","author":"Uslu","year":"2014","journal-title":"J Foot Ankle Surg"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/107110078800900105","article-title":"Soft tissue tumors of the foot and ankle","volume":"9","author":"Seale","year":"1988","journal-title":"Foot Ankle"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2106\/00004623-198971040-00018","article-title":"Soft-tissue tumors and tumor-like lesions of the foot. An analysis of eighty-three cases","volume":"71","author":"Kirby","year":"1989","journal-title":"J Bone Joint Surg Am"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00270-008-9382-9","article-title":"Central retinal and posterior ciliary artery occlusion after intralesional injection of sclerosant to glabellar subcutaneous hemangioma","volume":"32","author":"Matsuo","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/00006534-199910000-00037","article-title":"The role of sclerotherapy in abnormal varicose hand veins","volume":"104","author":"Duffy","year":"1999","journal-title":"Plast Reconstr Surg"},{"key":"R36-20250731","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0284185118795326","article-title":"Craniofacial venous malformations treated by percutaneous sclerotherapy using polidocanol: a single-center experience","volume":"60","author":"Grieb","year":"2019","journal-title":"Acta Radiol"},{"key":"R37-20250731","first-page":"46","article-title":"Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest","volume":"28","author":"Bowes","year":"2002","journal-title":"Dermatol Surg"},{"key":"R38-20250731","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0161-6420(00)00384-5","article-title":"Removal of periocular veins by sclerotherapy","volume":"108","author":"Green","year":"2001","journal-title":"Ophthalmology"},{"key":"R39-20250731","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1524-4725.1993.tb00976.x","article-title":"Treatment of facial telangiectasia with sclerotherapy, laser surgery, and\/or electrodesiccation: a review","volume":"19","author":"Goldman","year":"1993","journal-title":"J Dermatol Surg Oncol"},{"key":"R40-20250731","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0161-6420(00)00565-0","article-title":"Removal of periocular veins by sclerotherapy: editorial","volume":"180","author":"Fante","year":"2001","journal-title":"Ophthamology"},{"key":"R41-20250731","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0161-6420(00)00565-0","article-title":"Removal of periocular veins by sclerotherapy","volume":"108","author":"Fante","year":"2001","journal-title":"Ophthalmology"},{"key":"R42-20250731","first-page":"425","article-title":"Venous lake of the lip treated with a sclerosing agent: report of two cases","volume":"29","author":"Kuo","year":"2003","journal-title":"Dermatol Surg"},{"key":"R43-20250731","first-page":"46","article-title":"Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest","volume":"28","author":"Bowes","year":"2002","journal-title":"Dermatol Surg"},{"key":"R44-20250731","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1524-4725.2011.01972.x","article-title":"Rejuvenation of the chest: a review","volume":"37","author":"Peterson","year":"2011","journal-title":"Dermatol Surg"},{"issue":"Suppl 2","key":"R45-20250731","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1524-4725.2009.01470.x","article-title":"Letter: polidocanol sclerotherapy for the treatment of pyogenic granuloma","volume":"36","author":"Carvalho","year":"2010","journal-title":"Dermatol Surg"},{"key":"R46-20250731","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1524-4725.2010.01723.x","article-title":"Microcystic lymphatic malformation (lymphangioma circumscriptum) treated using a minimally invasive technique of radiofrequency ablation and sclerotherapy","volume":"36","author":"Niti","year":"2010","journal-title":"Dermatol Surg"},{"key":"R47-20250731","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/DSS.0000000000000601","article-title":"Treatment of 63 subjects with digital mucous cysts with percutaneous sclerotherapy using polidocanol","volume":"42","author":"Esson","year":"2016","journal-title":"Dermatol Surg"},{"key":"R48-20250731","first-page":"1387","article-title":"Treatment of digital mucous cysts with percutaneous sclerotherapy using polidocanol","volume":"34","author":"C\u00f3rdoba","year":"2008","journal-title":"Dermatol Surg"},{"key":"R49-20250731","first-page":"749","article-title":"Mixed skin ulcers misdiagnosed as pyoderma gangrenosum and rheumatoid ulcer: successful treatment with ultrasound-guided injection of polidocanol microfoam","volume":"32","author":"Lloret","year":"2006","journal-title":"Dermatol Surg"},{"key":"R50-20250731","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jdcr.2016.11.003","article-title":"Focal cutaneous mucinosis after knee replacement: a rare entity successfully treated with intralesional polidocanol","volume":"3","author":"Juhl","year":"2017","journal-title":"JAAD Case Rep"},{"key":"R51-20250731","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1258\/phleb.2012.011152","article-title":"Polidocanol foam sclerotherapy of persisting postoperative seromas after varicose vein surgery: a series of six cases","volume":"28","author":"Moritz","year":"2013","journal-title":"Phlebology"},{"key":"R52-20250731","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4103\/0974-2077.197083","article-title":"Familial disseminated cutaneous glomuvenous malformation: treatment with polidocanol sclerotherapy","volume":"9","author":"Jha","year":"2016","journal-title":"J Cutan Aesthet Surg"},{"key":"R53-20250731","doi-asserted-by":"crossref","first-page":"e13505","DOI":"10.1111\/dth.13505","article-title":"Intralesional sclerotherapy for the treatment of acne cysts: a case series","volume":"33","author":"Bhattacharjee","year":"2020","journal-title":"Dermatol Ther"},{"key":"R54-20250731","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1468-3083.2009.03546.x","article-title":"Polidocanol foam sclerotherapy is a new and effective treatment for post-operative lymphorrhea and lymphocele","volume":"24","author":"Klode","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R55-20250731","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/DSS.0000000000003035","article-title":"Intracavitary foam sclerotherapy in dissecting cellulitis of the scalp","volume":"47","author":"Aboul-Fettouh","year":"2021","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:07:40Z","timestamp":1753999660000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000003520","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]}}}